机译:Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
Yonsei Cancer Centre Yonsei University College of Medicine;
Hospital Universitario Insular de Gran Canaria;
SCRI Florida Cancer SpecialistsUnidad de Gestión Clínica Intercentros Medical Oncology Hospitales Universitarios Regional y VirgenInstitute of Lung Diseases VojvodinaChungbuk National University HospitalHospital Universitario de Alicante-ISABIALInstitute de Cancerologie de l'OuestNational Taiwan University Cancer CentreAix Marseille University CNRS INSERM CRCMAsan Medical CenterHospital Universitario Doce de OctubreGenentech South San FranciscoSarah Cannon Research Institute–Tennessee Oncology;